Cargando…
A new variant of the human α-lactalbumin-oleic acid complex as an anticancer agent for chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of hematopoietic stem cells. Although there have been advancements in treatment, there is still a need to develop a biotherapeutic agent. A new variant of the human alpha-lactalbumin-oleic acid (HALOA) complex has been synthesize...
Autores principales: | Singh, Vivek, Singh, Ranjana, Kumar, Dinesh, Mahdi, Abbas Ali, Tripathi, Anil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742887/ https://www.ncbi.nlm.nih.gov/pubmed/35027964 http://dx.doi.org/10.25122/jml-2021-0065 |
Ejemplares similares
-
The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
por: Singh, Vivek, et al.
Publicado: (2022) -
The bioengineered HALOA complex induces anoikis in chronic myeloid leukemia cells by targeting the BCR-ABL/Notch/Ikaros/Redox/Inflammation axis
por: Singh, Vivek, et al.
Publicado: (2022) -
The cytotoxicity of BAMLET complexes is due to oleic acid and independent of the α-lactalbumin component
por: Delgado, Yamixa, et al.
Publicado: (2015) -
Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy
por: Pei, Wei, et al.
Publicado: (2022) -
Leukocyte superoxide dismutase activity in patients with chronic myeloid leukemia
por: Ahmad, Rizwan, et al.
Publicado: (2012)